Molecular mechanisms of pathogenesis of Parkinson's disease.
about
Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanismsParaoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?Manganese superoxide dismutase: guardian of the powerhouse.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Inhibition of polyisoprenylated methylated protein methyl esterase by synthetic musks induces cell degeneration.Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats.Testosterone replacement attenuates haloperidol-induced catalepsy in male rats.Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular studyAdeno-associated virus vectors and neurological gene therapy.Metabolic Alterations and the Protective Effect of Punicalagin Against Glutamate-Induced Oxidative Toxicity in HT22 Cells.Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell modelDopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D.8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats.NMDA receptor genotypes associated with the vulnerability to develop dyskinesiaInhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP+) induced neurotoxicity in differentiated PC12 cells.
P2860
Q34109658-CEAC2670-8A99-414F-8B44-05D129C1A649Q35163293-990F70DC-B120-42DF-BC0C-7909B92EE9FFQ35536092-E54B74DD-B752-4309-9DE0-E19D61252B68Q35971342-13F936D2-A611-43B4-BE54-7D95605C3136Q36844098-2A68A6DE-D72C-497C-A2D7-A67378AC0978Q37043711-ECE4B4BF-1723-4E6A-8262-BD0CC6B4AAC5Q37712490-9E9B10CB-A78F-46DF-BF42-AD7B65F5A776Q37725727-7523F4EC-ADF6-409D-9396-80BF2E7433F8Q38190041-58845DA7-11FD-446D-BCD0-291C69C32143Q38722148-80068BC8-45DE-4891-B21E-EB9C2380EBDEQ38909797-90D544E9-5138-40F4-A4BA-5DC8298C5857Q39100342-7C637E56-D98B-484D-BA65-EEBAC076562AQ39367606-7DAA1C64-69FA-4A73-8D09-646C02A96F74Q41975992-6DA4C245-14A4-4C75-AD9E-39451C6435AFQ42072420-79278FCC-4D7A-4B8F-9F1D-E837AFEFF64CQ46247320-E60D3205-A501-4DCA-8F9F-46596F81DF3D
P2860
Molecular mechanisms of pathogenesis of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of pathogenesis of Parkinson's disease.
@en
Molecular mechanisms of pathogenesis of Parkinson's disease.
@nl
type
label
Molecular mechanisms of pathogenesis of Parkinson's disease.
@en
Molecular mechanisms of pathogenesis of Parkinson's disease.
@nl
prefLabel
Molecular mechanisms of pathogenesis of Parkinson's disease.
@en
Molecular mechanisms of pathogenesis of Parkinson's disease.
@nl
P1476
Molecular mechanisms of pathogenesis of Parkinson's disease
@en
P2093
S A Limborska
P304
P356
10.1016/S1937-6448(10)81006-8
P577
2010-01-01T00:00:00Z